HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – HC Wainwright issued their FY2027 EPS estimates for shares of HIVE Blockchain Technologies in a research report issued to clients and investors on Monday, August 17th. HC Wainwright analyst M. Colonnese anticipates that the company will post earnings per share of ($0.70) for the year.
Separately, Chardan Capital raised HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Monday, July 27th. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, HIVE Blockchain Technologies presently has an average rating of “Buy”.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
